Erythropoietin Receptor (EpoR)

Erythropoietin receptor (EpoR) is a receptor present on erythroid progenitor cells, belonging to the type I cytokine receptor family and characterized by a single transmembrane domain. When EpoR binds to erythropoietin (EPO), it effectively inhibits cell apoptosis and stimulates the production of red blood cells.
Activation of EpoR leads to the activation of downstream intracellular signaling pathways, including the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) pathway, the mitogen-activated protein kinase (MAPK) pathway, and the signal transducer and activator of transcription (STAT) pathway.
In erythroid lineage cells, the expression of EpoR is crucial for the normal development of mammals. Furthermore, EpoR plays a pivotal role in the complex cascade responses to acute and chronic hypoxic injuries in the body, particularly within the cardiovascular system. EpoR has driven research into the beneficial effects of erythropoietin in various diseases, primarily cardiovascular diseases[1].

共 1种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
STS-E412

STS-E412 是一种组织保护性 EPO 受体(包括 EPOR 和 CD131)的选择性激活剂,可用于神经退行性疾病和器官保护研究。

1609980-39-3
Activator
98.56%
STS-E412

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础